Synthaverse received PLN 45 million loan approval, and Synthaverse stock costs EUR 0.63

Published on 10/20/2026 at 13:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Annual financing costs could fall by PLN 5.32 million under the plan. Synthaverse stock costs EUR 0.63 on October 20, 2026 during trading.

Financing and operating milestones

Synthaverse received PLN 45 million loan approval on October 16, 2026.
First-half revenue reached PLN 26.46 million in 2026, up 34.20 percent year over year.
Synthaverse stock trades at EUR 0.63 at 1:49 p.m. CEST at Lang & Schwarz on October 20, 2026.

Biomed Lublin, PLBMDLB00018, Illustration mit AI erstellt.

Synthaverse (ISIN PLBMDLB00018) was trading at EUR 0.63 at Lang & Schwarz on October 20, 2026 at 1:49 p.m. CEST. The company had received binding confirmation of a PLN 45 million loan decision from the Industrial Development Agency on October 16, 2026, according to Bankier.pl.

Refinancing changes the debt timetable

The proposed ARP financing is intended to refinance debt owed to ACP and would run for up to 120 months. Principal payments could be deferred for up to 24 months, followed by 96 equal monthly installments, while the interest margin starts at 3.5 percentage points above WIBOR 1M, according to the October 16, 2026 report.

Management estimates that the planned structure could reduce annual financing costs by PLN 5.32 million. The proposal also includes an equity issue, and the final number of shares, issue price and investor group depend on subsequent corporate decisions, as Poland 24 reported on October 17, 2026.

What does the refinancing mean for operations?

The financing plan matters because Synthaverse entered the second half of 2026 with stronger operating revenue but a deeper net loss. Revenue for the first half of 2026 rose to PLN 26.46 million from PLN 19.71 million in the first half of 2025, a 34.20 percent increase, while net loss reached PLN 6.37 million versus PLN 5.31 million, according to MarketScreener.

Three financing milestones

On September 23, 2026, Synthaverse obtained a positive mBank credit decision that could lift its overdraft limit from PLN 3.5 million to PLN 15 million. On September 30, 2026, the company reported first-half revenue of PLN 26.46 million. On October 16, 2026, it disclosed the PLN 45 million ARP loan decision, with the three events documented in the company filing carried by Bankier.pl.

Next reporting checkpoint

The next scheduled reporting date is December 2, 2026, according to Investing.com. The financing plan also points to the fourth quarter of 2028 for the first principal repayments if the agreement is signed in the fourth quarter of 2026 and the full grace period is used.

Stock trades during financing review

Synthaverse is listed on the Warsaw Stock Exchange under ticker SVE and operates in pharmaceuticals, with products including biological medicines, vaccines and laboratory reagents. The stock was trading at EUR 0.63 at Lang & Schwarz on October 20, 2026 at 1:49 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Synthaverse stock.